TrialEpilepsia2022

Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial.

Elizabeth A Thiele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.